US Patent Issued to InspirMed on Jan. 27 for "Inhalable liposomal sustained release composition for use in treating pulmonary diseases" (Taiwanese, American Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,313, issued on Jan. 27, was assigned to InspirMed Corp. (Taipei, Taiwan).

"Inhalable liposomal sustained release composition for use in treating pulmonary diseases" was invented by Keelung Hong (South San Francisco, Calif.), Jonathan Fang (South San Francisco, Calif.), Yu-Cheng Tseng (Taipei, Taiwan), Ting-Yu Cheng (Taipei, Taiwan), Wan-Ni Yu (Taipei, Taiwan) and Jo-Hsin Tang (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a liposomal sustained-release composition for use in treatment of pulmonary disease. The liposomal sustained release composition comprises a liposome that includes a polyethylene glycol (PEG)-modified li...